Pulmonary hypertension as a risk factor for death in patients with sickle cell disease

被引:926
作者
Gladwin, MT
Sachdev, V
Jison, ML
Shizukuda, Y
Plehn, JF
Minter, K
Brown, B
Coles, WA
Nichols, JS
Ernst, I
Hunter, LA
Blackwelder, WC
Schechter, AN
Rodgers, GP
Castro, O
Ognibene, FP
机构
[1] NHLBI, Dept Crit Care Med, Ctr Clin, NIH, Bethesda, MD 20892 USA
[2] NHLBI, Cardiovasc Branch, NIH, Bethesda, MD 20892 USA
[3] NIDDKD, Lab Chem Biol, NIH, Bethesda, MD 20892 USA
[4] NIDDKD, Mol & Clin Hematol Branch, NIH, Bethesda, MD 20892 USA
[5] Howard Univ, Coll Med, Dept Med, Div Cardiol, Washington, DC USA
[6] Howard Univ, Coll Med, Ctr Sickle Cell Dis, Washington, DC USA
关键词
D O I
10.1056/NEJMoa035477
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: The prevalence of pulmonary hypertension in adults with sickle cell disease, the mechanism of its development, and its prospective prognostic significance are unknown. METHODS: We performed Doppler echocardiographic assessments of pulmonary-artery systolic pressure in 195 consecutive patients (82 men and 113 women; mean [+/-SD] age, 36+/-12 years). Pulmonary hypertension was prospectively defined as a tricuspid regurgitant jet velocity of at least 2.5 m per second. Patients were followed for a mean of 18 months, and data were censored at the time of death or loss to follow-up. RESULTS: Doppler-defined pulmonary hypertension occurred in 32 percent of patients. Multiple logistic-regression analysis, with the use of the dichotomous variable of a tricuspid regurgitant jet velocity of less than 2.5 m per second or 2.5 m per second or more, identified a self-reported history of cardiovascular or renal complications, increased systolic blood pressure, high lactate dehydrogenase levels (a marker of hemolysis), high levels of alkaline phosphatase, and low transferrin levels as significant independent correlates of pulmonary hypertension. The fetal hemoglobin level, white-cell count, and platelet count and the use of hydroxyurea therapy were unrelated to pulmonary hypertension. A tricuspid regurgitant jet velocity of at least 2.5 m per second, as compared with a velocity of less than 2.5 m per second, was strongly associated with an increased risk of death (rate ratio, 10.1; 95 percent confidence interval, 2.2 to 47.0; P<0.001) and remained so after adjustment for other possible risk factors in a proportional-hazards regression model. CONCLUSIONS: Pulmonary hypertension, diagnosed by Doppler echocardiography, is common in adults with sickle cell disease. It appears to be a complication of chronic hemolysis, is resistant to hydroxyurea therapy, and confers a high risk of death. Therapeutic trials targeting this population of patients are indicated.
引用
收藏
页码:886 / 895
页数:10
相关论文
共 44 条
[1]   Prevention of a first stroke by transfusions in children with sickle, cell anemia and abnormal results on transcranial Doppler ultrasonography [J].
Adams, RJ ;
McKie, VC ;
Hsu, L ;
Files, B ;
Vichinsky, E ;
Pegelow, C ;
Abboud, M ;
Gallagher, D ;
Kutlar, A ;
Nichols, FT ;
Bonds, DR ;
Brambilla, D ;
Woods, G ;
Olivieri, N ;
Driscoll, C ;
Miller, S ;
Wang, W ;
Hurlett, A ;
Scher, C ;
Berman, B ;
Carl, E ;
Jones, AM ;
Roach, ES ;
Wright, E ;
Zimmerman, RA ;
Waclawiw, M ;
Pearson, H ;
Powars, D ;
Younkin, D ;
El-Gammal, T ;
Seibert, J ;
Moye, L ;
Espeland, M ;
Murray, R ;
McKinley, R ;
McKinley, S ;
Hagner, S ;
Weiner, S ;
Estow, S ;
Yelle, M ;
Brock, K ;
Carter, E ;
Chiarucci, K ;
Debarr, M ;
Feron, P ;
Harris, S ;
Hoey, L ;
Jacques, K ;
Kuisel, L ;
Lewis, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (01) :5-11
[2]  
Adedeji MO, 2001, ARCH PATHOL LAB MED, V125, P1436
[3]   Cardiac involvement in thalassemia intermedia: a multicenter study [J].
Aessopos, A ;
Farmakis, D ;
Karagiorga, M ;
Voskaridou, E ;
Loutradi, A ;
Hatziliami, A ;
Joussef, J ;
Rombos, J ;
Loukopoulos, D .
BLOOD, 2001, 97 (11) :3411-3416
[4]   Doppler evaluation of left and right ventricular diastolic function: A technical guide for obtaining optimal flow velocity recordings [J].
Appleton, CP ;
Jensen, JL ;
Hatle, LK ;
Oh, JK .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 1997, 10 (03) :271-292
[5]   Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease [J].
Aslan, M ;
Ryan, TM ;
Adler, B ;
Townes, TM ;
Parks, DA ;
Thompson, JA ;
Tousson, A ;
Gladwin, MT ;
Patel, RP ;
Tarpey, MM ;
Batinic-Haberle, I ;
White, CR ;
Freeman, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (26) :15215-15220
[6]   Pharmacologic induction of fetal hemoglobin: raising the therapeutic bar in sickle cell disease [J].
Atweh, GF ;
Schechter, AN .
CURRENT OPINION IN HEMATOLOGY, 2001, 8 (02) :123-130
[7]   QUANTITATIVE ASSESSMENT OF PULMONARY-HYPERTENSION IN PATIENTS WITH TRICUSPID REGURGITATION USING CONTINUOUS WAVE DOPPLER ULTRASOUND [J].
BERGER, M ;
HAIMOWITZ, A ;
VANTOSH, A ;
BERDOFF, RL ;
GOLDBERG, E .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :359-365
[8]   Systemic fat embolism and pulmonary hypertension in sickle cell disease [J].
Castro, O .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (06) :1289-&
[9]   Pulmonary hypertension in sickle cell disease: cardiac catheterization results and survival [J].
Castro, O ;
Hoque, M ;
Brown, BD .
BLOOD, 2003, 101 (04) :1257-1261
[10]   CAN TWO-DIMENSIONAL ECHOCARDIOGRAPHY AND DOPPLER COLOR FLOW MAPPING IDENTIFY THE NEED FOR TRICUSPID-VALVE REPAIR [J].
CHOPRA, HK ;
NANDA, NC ;
FAN, P ;
KAPUR, KK ;
GOYAL, R ;
DARUWALLA, D ;
PACIFICO, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (05) :1266-1274